AzTrials
AzTrials

Mothers of Newborn InfantsPhase 3NCT01637779

A Randomized Controlled Trial About Teaching Parents How to Manage Childhood Immunization Pain

A Phase 3 study testing Fact sheet in people with Mothers of Newborn Infants, run by University of Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There is no effect of a parent-directed fact sheet about pain management during childhood immunization and pre-test on parent learning about evidence-based pain relieving methods. Read more about this study

Who is it for?
Ages 15 to 60 years, women only
Conditions the study is for
Mothers of Newborn Infants
What is being tested?
Fact sheet
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteCanada
Study dates
Jul 2012to Feb 2013
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 60 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • new mothers with health full-term infants
  • 5 minute Apgar 7 or more

Who cannot join

  • non-english speaking mothers
  • mothers with psychiatric conditions
  • infants admitted to intensive care unit

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Mount Sinai Hospital

    Toronto, Ontario, M5G 1X5

Other trials in Canada

About this study

Official title: A Randomized Clinical Trial to Evaluate the Impact of a Fact Sheet About Childhood Immunization Pain Management on Parental Knowledge

There is no effect of a parent-directed fact sheet about pain management during childhood immunization and pre-test on parent learning about evidence-based pain relieving methods.

Read the detailed description

Over 90% of young children demonstrate severe distress during vaccination. Pain relieving strategies are uncommonly used, despite a plethora of evidence for physical, pharmacological and psychological techniques. Parents commonly report pain as a harm-related concern for childhood immunizations and are dissatisfied with current practices. Unmitigated pain causes long-term adverse sequelae, including; anticipatory fear and hypersensitivity to pain at future procedures in children, and parental non-compliance with immunization schedules. Health providers and parents report the major barrier to routine use of pain management is parental lack of knowledge about effective strategies. Lack of time is reported as a secondary barrier. An educational tool about immunization pain management targeted to parents that can be practically implemented in the clinical setting within usual time constraints is needed.

Being tested
Fact sheet
Keywords
randomized controlled trial, parent education, pain management, infant, immunization
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fact sheetBehavioural

    fact sheet about pain management during immunization

Study groups in NCT01637779
Study groupRoleWhat they receive
fact sheet reviewExperimentalmothers will review a fact sheet containing information about pain management during immunization then complete a knowledge test afterward
Receives: Behavioral: Fact sheet
control unrelated materialPlacebo comparatormothers will review material unrelated to pain management during immunization then complete a knowledge test
Receives: Behavioral: Fact sheet
pre-test, review of fact sheetExperimentalmothers do a pre-test, then read a fact sheet about how to manage immunization pain, then repeat the test
Receives: Behavioral: Fact sheet
pre-test, control unrelated informationPlacebo comparatormothers do a pre-test, then read unrelated material, then repeat the test
Receives: Behavioral: Fact sheet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. knowledge

    maternal knowledge will be evaluated after reading the fact sheet or control (material unrelated to immunization)

    Measured: 10 minutes after intervention (educational material)

Secondary outcomes (1)
  1. utilization of pain relieving interventions

    maternal self-reported use of pain relieving interventions during routine 2-month infant immunizations

    Measured: 2 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2012 (estimated)
  2. Study startJul 2012
  3. Primary completionFeb 2013
  4. Study completionFeb 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01637779
Sponsor's protocol ID
11-0231-E
Other IDs
1000032989
Status last verified
Oct 2013
First submitted
8 Jul 2012
Last updated
29 Oct 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Fact sheet in people with Mothers of Newborn Infants, run by University of Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

knowledge (time frame: 10 minutes after intervention (educational material)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2013; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in